What Is DIHEXA?

DIHEXA is a small peptide developed from the angiotensin IV scaffold and engineered for one property above all: metabolic stability. Most cognition-research peptides fight a losing battle against degradation; DIHEXA was built to survive it.

What is DIHEXA?

Angiotensin IV is a short fragment of the angiotensin system with cognitive-research interest of its own, but a lifespan measured in minutes. DIHEXA is its stability-engineered descendant — modified end to end so it persists long enough for protocols to ask sustained questions. Its activity is associated in the research literature with the HGF/c-Met signalling system, an unusual mechanism among cognition probes.

What researchers study it for

DIHEXA appears in cognition and synaptogenesis research, where the HGF/c-Met association gives it a lever distinct from the cholinergic and neurotrophin probes that dominate the field — and from stabilised neuropeptides like Semax, which reach durability by gentler modifications. For researchers, the design lesson mirrors what the catalogue's other engineered molecules teach: stability decides what an experiment can ask, a theme covered from the manufacturing side in how research peptides are made.

Working with research-grade DIHEXA

REPRIME supplies DIHEXA as a lyophilized 10 mg vial, HPLC-verified per batch with a public COA and first-scan verification code. See the DIHEXA product page. Research use only.

Frequently asked questions

What is DIHEXA?

A stability-engineered peptide derived from the angiotensin IV scaffold, studied in cognition and synaptogenesis research through the HGF/c-Met system.

What makes DIHEXA unusual among cognition-research peptides?

Two things: its engineered resistance to degradation, and its association with HGF/c-Met signalling rather than the field's more common cholinergic or neurotrophin mechanisms.

How is research-grade DIHEXA supplied?

As a lyophilized 10 mg vial with batch HPLC verification, a public COA, and a verification code — see the product page.